Ramipril
Ramiprilis indicated in the following cases: Mild to severe hypertension Congestive Heart failure. To reduce the risk of stroke, myocardial infarction and death from cardiovascular events in patients ...
Ramipril + Hydrochlorothiazide
Indicated for the treatment of mild to moderate hypertension in patients (in whom combination therapy is appropriate) who have been stabilised on the individual components given in the same proportion.
Ranibizumab
Ranibizumab is indicated for the treatment of patients with: Neovascular (Wet) Age-Related Macular Degeneration (AMD) Macular Edema Following Retinal Vein Occlusion (RVO) Diabetic Macular Edema ...
Ranitidine Hydrochloride
Ranitidine is indicated in: Treatment of active duodenal ulcer Benign gastric ulcer Treatment prevention of ulcer associated with non-steroidal anti-inflammatory agent Post operative stress ulcer....
Ranolazine
Ranolazine is indicated for the treatment of chronic angina. Ranolazine may be used with beta-blockers, nitrates, calcium channel blockers, anti-platelet therapy, lipid-lowering therapy, ACE inhibitors, ...
Rasagiline
Rasagiline is indicated for the treatment of the signs and symptoms of idiopathic Parkinson's disease as initial monotherapy, and as adjunct therapy to dopamine agonists or to levodopa.
Recombinant Follicle Stimulating Hormone (rFSH)
In the Female: Ovulation Induction: rFSH administered SC with HCG in a sequential manner, which is indicated for ovulation induction in patients who have previously received pituitary suppression....
Regorafenib
Regorafenib is a kinase inhibitor that is indicated: For the treatment of metastatic colorectal cancer (CRC) after disease progression on or intolerance to fluoropyrimidine-based chemotherapy, anti-VEGF ...